Viewing Study NCT00904202


Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2025-12-26 @ 2:54 AM
Study NCT ID: NCT00904202
Status: COMPLETED
Last Update Posted: 2024-01-02
First Post: 2009-05-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Sponsor: Endo Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EN3220-009
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Sr Director, Clinical R&D
Old Organization: Endo Pharmaceuticals Inc

Collaborators